# Zydus Wellness (ZYDUSWELL) — Stock analysis

> Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/zyduswell

## Current market snapshot

- Exchange: NSE
- Country: India
- Price: ₹470
- Change: -0.99%
- As of: 2026-11-06
- 1D return: -0.99%
- 5D return: +1.57%
- 1M return: -5.20%
- Latest complete quarter: fy27_q2

## Faxioms Analysis

_As of 2026-11-06_

### Technical Outlook

ZYDUSWELL closed at ₹470.00 on 2026-11-06, reflecting a -1.0% daily decline after a wide intraday range (+14.9%) and a significant volume surge on 2026-11-03. The technical setup is defined by a conflict between short-term weakness and longer-term structure. On the daily chart, price sits below all key moving averages (EMA/SMA 20/50/200) and the Supertrend, which is bearish, with an ADX of 23.23 indicating developing but not yet strong trend conviction. Conversely, the monthly timeframe remains bullish, with price above its moving averages and Supertrend, supported by an established trend (ADX 30.4). The stock is trading near the lower end of its 20-day and 50-day ranges (+21.5% and +12.3% respectively) but in the middle of its 252-day range (+41.9%). Current drawdown stands at -22.0%, with annualized volatility at 35.9%. Immediate resistance lies at ₹483.45 (pivot) and ₹485.52 (high), while support is found at ₹461.05 and ₹458.70.

- Timeframe Conflict: Daily trend is bearish (price below all MAs and Supertrend), while monthly trend remains bullish (price above all MAs and Supertrend).
- Price Positioning: Trading at ₹470.00, near the lower end of the 20-day (+21.5%) and 50-day (+12.3%) ranges, but mid-range for the year (+41.9%).
- Key Levels: Resistance at ₹483.45 (pivot) and ₹485.52; Support at ₹461.05 and ₹458.70.
- Risk Metrics: Annualized volatility is 35.9%; current drawdown is -22.0% against a maximum historical drawdown of -28.8%.

- Outside Bar
- Inside Bar
- Bullish Engulfing Reversal
- Doji
- Bearish Engulfing Reversal

### News Context

Zydus Wellness Ltd reported its Q2 FY27 results for the period ending September 2026, revealing a significant divergence between top-line growth and bottom-line profitability. Revenue surged 73.2% to ₹1,126.6 crore, driven by double-digit growth in key brands such as Sugar Free, Nutralite, and Everyuth. This expansion contributed to an EBITDA margin improvement of 400 basis points year-on-year, reaching 7.6%. However, the company’s profit after tax (PAT) was limited to ₹5 crore, a sharp reversal from the ₹53 crore loss recorded in the same quarter last year. This modest profit figure reflects the impact of exceptional costs associated with the liquidation of Naturell (India) Pvt Ltd and the acquisition of Comfort Click Ltd, alongside one-time impacts from new labour codes. Despite these headwinds, an exceptional gain of ₹7 crore aided the final PAT figure. Following the announcement on November 3, 2026, the stock price rose 8%, indicating market reaction to the revenue surge and margin expansion despite the profit constraints.

- Revenue grew 73.2% to ₹1,126.6 crore in Q2 FY27, with double-digit growth across major brands including Sugar Free, Nutralite, and Everyuth.
- PAT stood at ₹5 crore, recovering from a ₹53 crore loss in the prior-year period, but weighed down by exceptional expenses from the Naturell liquidation and Comfort Click acquisition.
- EBITDA margins expanded by 400 basis points year-on-year to 7.6%, supported by an exceptional gain of ₹7 crore.
- The share price increased 8% following the results release on November 3, 2026.

- [Zydus Wellness Q2 profit at ₹5 crore despite 75% revenue growth; exceptional costs weigh](https://www.thehindubusinessline.com/companies/zydus-wellness-q2-profit-at-5-crore-despite-75-revenue-growth-exceptional-costs-weigh/article71660462.ece)
- [Zydus Wellness Q2 Results: Stock jumps 8% after 73% revenue growth; Exceptional gain aids PAT](https://www.cnbctv18.com/market/zydus-wellness-q2-results-profit-vs-loss-exceptional-items-margin-expansion-share-price-surge-20025819.htm)

### Official Filings

Zydus Wellness Limited reported unaudited financial results for the quarter and half-year ended September 30, 2026, alongside a press release detailing significant growth in sales and profitability. For Q2 FY27, net sales rose 74.6% to ₹11,227 million from ₹6,429 million in the prior-year period, while EBITDA increased 271.7% to ₹855 million. Half-year H1 FY27 sales reached ₹25,526 million (up 70.1%) with EBITDA at ₹3,272 million (up 83.2%). The company also addressed regulatory scrutiny, confirming receipt of an FSSAI notice regarding alleged misleading product claims on September 24, 2026, and submitted a response asserting factual and scientifically substantiated label statements. The company stated there is no material impact from this news article.

- Q2 FY27 Net Sales: ₹11,227 million, up 74.6% year-on-year from ₹6,429 million.
- Q2 FY27 EBITDA: ₹855 million, up 271.7% year-on-year.
- H1 FY27 Performance: Sales of ₹25,526 million (up 70.1%) and EBITDA of ₹3,272 million (up 83.2%).
- Regulatory Update: Company responded to an FSSAI notice received on September 24, 2026, regarding product claims, stating no material impact.

- [Zydus Wellness Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_04112026165704_SEintimationad.pdf)
- [Zydus Wellness Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026122955_SEintimationOutcomeofBM.pdf)
- [Zydus Wellness Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026123924_SEintimationInvestorPresentation.pdf)
- [Zydus Wellness Limited has informed the Exchange regarding a press release dated November 03, 2026, titled "Press Release". |SUBJECT: Press Release](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026124413_SEintimationPressRelease.pdf)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1751942_03112026054236_WEB.xml)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1751941_03112026054208_WEB.xml)
- [Integrated Filing- Financials|Revision|Updation in RPT](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1752345_03112026104648_WEB.xml)
- [Zydus Wellness Limited has informed the Exchange about Link of Recording |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026232253_SEintimationAudiorecording.pdf)
- [Zydus Wellness Limited has informed the Exchange about Audio Recording/Video Recording |SUBJECT: Analyst/Investor Meet Para A-XBRL](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_2952_WebXMLFile_20261103_232847217.xml)
- [The Exchange has sought clarification from Zydus Wellness Limited with respect to recent news item captioned FSSAI issues notices to Nestle India, Zydus Wellness over alleged misleading product claims.. The response from the Company is attached. |SUBJECT: News Verification](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_23102026102454_SEintimationnewsclarification.pdf)

### Fundamentals

Zydus Wellness is navigating a significant capital expansion phase, evidenced by borrowings rising from ₹188 crore in Mar 2025 to ₹3,167 crore by Sep 2026, while Fixed Assets grew to ₹8,602 crore. This leverage has materially impacted earnings quality; despite TTM sales of ₹5,013 crore (up 74% YoY in Q2 FY2026-27), interest costs surged to ₹133 crore (TTM) and ₹27.2 crore in the latest quarter, compressing net profit to just ₹5.1 crore in Q2 FY2026-27 against ₹119 crore in Q1. Cash conversion has weakened, with CFO/EBITDA dropping to 50% in Mar 2026 and cash reserves falling sharply to ₹36.7 crore as of Sep 2026. While promoter holding remains stable at ~69.6%, the combination of high debt servicing, declining cash buffers, and low ROCE (5%) suggests the company is in a heavy investment cycle where top-line growth has not yet translated into bottom-line resilience.

- Debt Surge: Borrowings increased nearly 17x from Mar 2025 (₹188 cr) to Sep 2026 (₹3,167 cr), funding asset expansion but raising annualized interest expenses to ₹133 crore (TTM).
- Margin Compression: Net profit collapsed to ₹5.1 crore in Q2 FY2026-27 (EPS ₹0.16) despite 73% YoY sales growth, driven by high interest (₹27.2 cr) and depreciation (₹57.1 cr).
- Cash Flow Stress: Cash from financing activity was positive ₹2,698 crore in Mar 2026 (debt raise), while cash reserves dropped to ₹36.7 crore by Sep 2026; CFO/EBITDA ratio fell to 50% in Mar 2026.
- Low Returns: ROCE remained flat at 5% for Mar 2026, and Compounded Profit Growth is negative (-10% over 3 years), indicating current assets are not generating sufficient returns on the expanded capital base.

### Bull Case

Zydus Wellness reported a significant operational turnaround in Q2 FY27, with revenue surging 73.2% year-on-year to ₹1,126.6 crore and EBITDA margins expanding by 400 basis points to 7.6%. Net profit turned positive at ₹5 crore, reversing a ₹53 crore loss in the prior-year period, aided by an exceptional gain of ₹7 crore. This fundamental improvement triggered an 8% share price jump post-results. Technically, while daily trends remain bearish with the stock trading at ₹470.0 (a current drawdown of -22.0%), the monthly and weekly charts show bullish supertrend directions, suggesting longer-term structural support. The constructive case hinges on whether sustained double-digit growth across key brands like Sugar Free and Nutralite can offset recent one-time costs from the Naturell liquidation and Comfort Click acquisition.

- Q2 FY27 revenue grew 73.2% YoY to ₹1,126.6 crore, with EBITDA margin expanding 400 bps to 7.6%.
- Net profit recovered to ₹5 crore from a ₹53 crore loss last year, supported by a ₹7 crore exceptional gain.
- Monthly and weekly technical indicators signal bullish momentum, contrasting with bearish daily trends.
- Stock trades at ₹470.0 with a -22.0% current drawdown; upside requires holding above ₹461.05 support.

- [Zydus Wellness Q2 profit at ₹5 crore despite 75% revenue growth; exceptional costs weigh](https://www.thehindubusinessline.com/companies/zydus-wellness-q2-profit-at-5-crore-despite-75-revenue-growth-exceptional-costs-weigh/article71660462.ece)
- [Zydus Wellness Q2 Results: Stock jumps 8% after 73% revenue growth; Exceptional gain aids PAT](https://www.cnbctv18.com/market/zydus-wellness-q2-results-profit-vs-loss-exceptional-items-margin-expansion-share-price-surge-20025819.htm)
- [Zydus Wellness Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_04112026165704_SEintimationad.pdf)
- [Zydus Wellness Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026122955_SEintimationOutcomeofBM.pdf)
- [Zydus Wellness Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026123924_SEintimationInvestorPresentation.pdf)
- [Zydus Wellness Limited has informed the Exchange regarding a press release dated November 03, 2026, titled "Press Release". |SUBJECT: Press Release](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026124413_SEintimationPressRelease.pdf)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1751942_03112026054236_WEB.xml)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1751941_03112026054208_WEB.xml)
- [Integrated Filing- Financials|Revision|Updation in RPT](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1752345_03112026104648_WEB.xml)
- [Zydus Wellness Limited has informed the Exchange about Link of Recording |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026232253_SEintimationAudiorecording.pdf)

### Bear Case

Zydus Wellness faces significant near-term headwinds despite recent revenue growth. The company’s Q2 FY27 net profit was just ₹5 crore, heavily weighed down by exceptional expenses from the liquidation of Naturell (India) Pvt Ltd and the acquisition of Comfort Click Ltd, alongside one-time impacts from new labour codes. While EBITDA margins expanded to 7.6%, this remains a modest level for a consumer wellness brand. From a market perspective, the stock is in a pronounced downtrend on daily timeframes, with the Supertrend indicator signaling bearish momentum. The share price has suffered a current drawdown of -22.0% against a maximum historical drawdown of -28.8%, reflecting substantial investor erosion over the past six months (-7.5%) and three months (-11.6%). Technical resistance is immediate at ₹483.45, just 2.86% above the current close of ₹470.00, suggesting limited upside room without a clear reversal signal.

- Q2 FY27 PAT constrained to ₹5 crore due to exceptional costs from Naturell liquidation and Comfort Click acquisition, offsetting 73-75% revenue growth.
- Daily technical trend is bearish with a current drawdown of -22.0%; monthly returns are negative across 1-month (-6.4%), 3-month (-11.6%), and 6-month (-7.5%) horizons.
- Immediate resistance at ₹483.45 (2.86% above current price) limits short-term upside potential.
- High volatility persists with annualized volatility at +35.9% and an ATR of 4.72%, indicating elevated price risk.

- [Zydus Wellness Q2 profit at ₹5 crore despite 75% revenue growth; exceptional costs weigh](https://www.thehindubusinessline.com/companies/zydus-wellness-q2-profit-at-5-crore-despite-75-revenue-growth-exceptional-costs-weigh/article71660462.ece)
- [Zydus Wellness Q2 Results: Stock jumps 8% after 73% revenue growth; Exceptional gain aids PAT](https://www.cnbctv18.com/market/zydus-wellness-q2-results-profit-vs-loss-exceptional-items-margin-expansion-share-price-surge-20025819.htm)
- [Zydus Wellness Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_04112026165704_SEintimationad.pdf)
- [Zydus Wellness Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026122955_SEintimationOutcomeofBM.pdf)
- [Zydus Wellness Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026123924_SEintimationInvestorPresentation.pdf)
- [Zydus Wellness Limited has informed the Exchange regarding a press release dated November 03, 2026, titled "Press Release". |SUBJECT: Press Release](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026124413_SEintimationPressRelease.pdf)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1751942_03112026054236_WEB.xml)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1751941_03112026054208_WEB.xml)
- [Integrated Filing- Financials|Revision|Updation in RPT](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1752345_03112026104648_WEB.xml)
- [Zydus Wellness Limited has informed the Exchange about Link of Recording |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026232253_SEintimationAudiorecording.pdf)

### FAQs

**Why did Zydus Wellness report only ₹5 crore profit despite 75% revenue growth in Q2 FY27?**

The company posted net sales of ₹1,126.6 crore (up 73.2%) and an EBITDA margin expansion to 7.6%. However, Profit After Tax was limited to ₹5 crore due to exceptional expenses from the liquidation of Naturell (India) Pvt Ltd and acquisition of Comfort Click Ltd, alongside one-time impacts from new labour codes. These costs offset the strong top-line performance.

**How has Zydus Wellness's financial performance trended over the half-year period ending September 2026?**

For H1 FY27, consolidated net sales reached ₹25,526 million, up 70.1% year-on-year, while EBITDA grew 83.2% to ₹3,272 million. This follows a reversal from a ₹53 crore loss in the same quarter last year to a ₹5 crore profit in Q2 FY27, driven by double-digit growth across key brands like Sugar Free, Nutralite, and Everyuth.

**What are the current technical support and resistance levels for Zydus Wellness shares?**

As of November 6, 2026, the stock closed at ₹470.00. Immediate support lies at ₹461.05 (1.90% below), with further support at ₹458.70. Resistance is observed at ₹483.45 (2.86% above) and ₹485.52. The monthly trend remains bullish, though daily indicators show bearish momentum with a current drawdown of -22.0%.

- [Zydus Wellness Q2 profit at ₹5 crore despite 75% revenue growth; exceptional costs weigh](https://www.thehindubusinessline.com/companies/zydus-wellness-q2-profit-at-5-crore-despite-75-revenue-growth-exceptional-costs-weigh/article71660462.ece)
- [Zydus Wellness Q2 Results: Stock jumps 8% after 73% revenue growth; Exceptional gain aids PAT](https://www.cnbctv18.com/market/zydus-wellness-q2-results-profit-vs-loss-exceptional-items-margin-expansion-share-price-surge-20025819.htm)
- [Zydus Wellness Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_04112026165704_SEintimationad.pdf)
- [Zydus Wellness Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026122955_SEintimationOutcomeofBM.pdf)
- [Zydus Wellness Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026123924_SEintimationInvestorPresentation.pdf)
- [Zydus Wellness Limited has informed the Exchange regarding a press release dated November 03, 2026, titled "Press Release". |SUBJECT: Press Release](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026124413_SEintimationPressRelease.pdf)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1751942_03112026054236_WEB.xml)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1751941_03112026054208_WEB.xml)
- [Integrated Filing- Financials|Revision|Updation in RPT](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1752345_03112026104648_WEB.xml)
- [Zydus Wellness Limited has informed the Exchange about Link of Recording |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026232253_SEintimationAudiorecording.pdf)
## Technical analytics

- As of: 2026-11-06
- Daily trend: Moderate Downtrend
- Weekly trend: Weak Downtrend
- Pivot point: ₹483.45
- Risk regime: Price Risk Requires Attention

### Support levels
- 458.7
- 452.259375
- 404.125

### Resistance levels
- 485.515625
- 501.64374999999995
- 517.140625

### Return and range metrics

| Metric | Value |
| --- | --- |
| return_1 | -0.99% |
| return_10 | +1.44% |
| return_1m | -6.45% |
| return_1y | +5.90% |
| return_20 | -5.20% |
| return_3m | -11.57% |
| return_5 | +1.57% |
| return_6m | -7.49% |
| return_since_start | +18.92% |
| return_ytd | +1.24% |

### Risk and volatility metrics

| Metric | Value |
| --- | --- |
| state | elevated_risk |
| label | Price risk requires attention |
| summary | Recent drawdown or price variability is high enough to warrant closer monitoring. |
| maximum_drawdown | -28.76% |
| annualized_volatility | +35.92% |

## Quarterly financials

- Latest complete quarter: fy27_q2

# Zydus Wellness Q2 FY2026-27: Profit before tax falls 95% sequentially

Zydus Wellness reported revenue from operations of ₹1,126.6 crore for the quarter ended 30 September 2026, down 21.6% from Q1 FY2026-27 but up 73.2% year on year. Profit before tax fell to ₹7.6 crore from ₹162.1 crore in Q1, while profit for the period was ₹5.1 crore. Operating cash flow was ₹312.1 crore.

## Revenue and expenses

Revenue from operations declined by ₹310.4 crore quarter on quarter, from ₹1,437 crore in Q1 FY2026-27. Expenses fell 12.0% to ₹1,125.4 crore from ₹1,278.7 crore, a smaller decline than revenue. Q2 expenses included ₹315.9 crore for materials consumed, ₹132 crore for purchases of stock in trade, ₹88.8 crore in employee benefits and ₹57.1 crore in depreciation and amortisation.

Compared with Q2 FY2025-26, revenue rose from ₹650.5 crore and expenses increased from ₹668.3 crore. Profit before tax moved from a loss of ₹50.6 crore to a profit of ₹7.6 crore.

## Profitability and earnings

Profit before tax fell 95.3% from ₹162.1 crore in Q1 FY2026-27 to ₹7.6 crore in Q2. Finance costs edged up to ₹27.2 crore from ₹26.3 crore. Tax expense was ₹2.5 crore, versus ₹43.2 crore in Q1, and profit for the period declined to ₹5.1 crore from ₹118.9 crore.

Basic and diluted earnings per share were ₹0.16, down from ₹3.74 in Q1 FY2026-27. Trailing 12-month EPS was ₹7.74.

## Cash flow and liquidity

Operating cash flow was ₹312.1 crore, investing cash flow was negative ₹258.2 crore and financing cash flow was negative ₹127.8 crore. Reported free cash flow was ₹53.9 crore.

Cash and cash equivalents stood at ₹36.7 crore on 30 September 2026, down from ₹110.6 crore on 31 March 2026. Current investments were ₹221.3 crore at the September quarter-end, compared with ₹4.2 crore at the March year-end.

## Working capital and balance sheet

Inventories stood at ₹747.5 crore on 30 September 2026, down from ₹763.8 crore on 31 March 2026 but above ₹611.9 crore on 30 September 2025. Trade receivables were ₹284.3 crore, compared with ₹383.8 crore at the March year-end. Trade payables were broadly unchanged at ₹461.2 crore, versus ₹461.4 crore.

Borrowings comprised ₹3,000.3 crore of non-current borrowings and ₹152 crore of current borrowings at 30 September 2026. Goodwill was ₹4,940.3 crore and other intangible assets were ₹3,232.9 crore. Equity attributable to owners of the parent increased to ₹5,907.7 crore from ₹5,826 crore at 31 March 2026.

## Key Takeaway

The quarter saw a sharp sequential drop in revenue and an even steeper fall in profit before tax, with EPS down to ₹0.16. Positive operating cash flow and reported free cash flow offered a counterpoint, while year-on-year revenue growth was accompanied by a return to profit before tax from a loss in Q2 FY2025-26.

### Ratios

## Shareholding pattern

- Quarter: FY2027-Q2
- As of: 2026-09-30
- Promoter holding: +69.64%
- FII holding: +3.57%
- DII holding: +19.39%
- Mutual fund holding: +18.72%
- Retail holding: +5.20%
- Promoter pledged: +0.00%

### Major reported shareholders

- Zydus Lifesciences Limited — +57.59% (Bodies Corporate)
- Zydus Family Trust(Trustee:Mr. Pankaj R. Patel,Smt. Pritiben P. Patel, Dr. Sharvil P. Patel) — +12.01% (Trusts)
- Parag Parikh Flexi Cap Fund — +7.33%
- Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund — +5.78%
- Quant Mutual Fund - Quant Small Cap Fund — +4.02%
- Bajaj Finserv Small Cap Fund — +1.17%
- Prashant Babubhai Patel — +0.01%

## Official filings

- 2026-11-07 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_07112026151519_SEintimationtranscript.pdf)
- 2026-11-07 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_2952_WebXMLFile_20261107_151641145.xml)
- 2026-11-04 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_04112026165704_SEintimationad.pdf)
- 2026-11-03 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026122955_SEintimationOutcomeofBM.pdf)
- 2026-11-03 — Earnings Presentation: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026123924_SEintimationInvestorPresentation.pdf)
- 2026-11-03 — Press Release: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026124413_SEintimationPressRelease.pdf)
- 2026-11-03 — Financial Results Filing: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1751942_03112026054236_WEB.xml)
- 2026-11-03 — Financial Results Filing: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1751941_03112026054208_WEB.xml)
- 2026-11-03 — Financial Results Filing: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1752345_03112026104648_WEB.xml)
- 2026-11-03 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_03112026232253_SEintimationAudiorecording.pdf)
- 2026-11-03 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_2952_WebXMLFile_20261103_232847217.xml)
- 2026-10-23 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_23102026102454_SEintimationnewsclarification.pdf)
- 2026-10-22 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/content/RSS/Online_announcements.xml)
- 2026-10-19 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_19102026174021_SEintimationinvestorconcall.pdf)
- 2026-10-19 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_2952_WebXMLFile_20261019_174759960.xml)
- 2026-10-16 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_16102026153541_SEIntimationNSEESGScore2026.pdf)
- 2026-10-15 — Board Meeting Notice: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_15102026182418_SEintimationNoticeofBM.pdf)
- 2026-10-15 — Board Meeting Notice: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_2952_WebXMLFile_20261015_182731939.xml)
- 2026-10-15 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_2952_WebXMLFile_20261015_182731939.xml)
- 2026-10-13 — Shareholding Disclosure: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SHP_1736511_13102026101551_WEB.xml)
- 2026-10-08 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_08102026124558_SEintimationReg745.pdf)
- 2026-09-30 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_30092026161059_SEintimationad.pdf)
- 2026-09-18 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_18092026180033_SEintimationSMP.pdf)
- 2026-09-18 — Generic Announcement: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/CIM_2952_WebXMLFile_20260918_180547820.xml)
- 2026-09-18 — Management Change: Zydus Wellness Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/ZYDUSWELL_ROID_98593_KMP_Doc.zip)

## News and market events

- 2026-11-03 — The Hindu: **Zydus Wellness Q2 profit at ₹5 crore despite 75% revenue growth; exceptional costs weigh** — Zydus Wellness Ltd posted a Q2 FY27 PAT of ₹5 crore despite 75% revenue growth, as exceptional expenses related to the liquidation of Naturell (India) Pvt Ltd and acquisition of Comfort Click Ltd weighed on profits. The company also recognized a one-time impact from new labour codes while reporting double-digit growth across key brands like Sugar Free, Nutralite, and Everyuth. — [Source](https://www.thehindubusinessline.com/companies/zydus-wellness-q2-profit-at-5-crore-despite-75-revenue-growth-exceptional-costs-weigh/article71660462.ece)
- 2026-11-03 — CNBC-TV18: **Zydus Wellness Q2 Results: Stock jumps 8% after 73% revenue growth; Exceptional gain aids PAT** — Zydus Wellness reported a net profit of ₹5 crore for the September quarter, reversing a ₹53 crore loss in the same period last year, driven by 73.2% revenue growth to ₹1,126.6 crore and an exceptional gain of ₹7 crore. The company's EBITDA margin expanded by 400 basis points year-on-year to 7.6%, contributing to an 8% surge in its share price following the results announcement. — [Source](https://www.cnbctv18.com/market/zydus-wellness-q2-results-profit-vs-loss-exceptional-items-margin-expansion-share-price-surge-20025819.htm)
- 2026-10-21 — CNBC-TV18: **FSSAI issues notices to Nestle India, Zydus Wellness over claims on infant and child products** — The food safety regulator has sought scientific evidence for claims about infant formula benefits and Complan’s promise of faster growth. It has also issued notices over an Instagram promotion involving infant milk substitutes, as scrutiny of packaged foods intensifies. — [Source](https://www.cnbctv18.com/business/fssai-notice-nestle-india-zydus-wellness-infant-child-product-claims-20016433.htm)
- 2026-10-21 — MONEYCONTROL: **‘2X faster growth’, ‘easy to digest’: FSSAI questions Complan, Nestle claims, seeks scientific proof** — FSSAI notice to Nestle, FSSAI notice to Zydus Wellness, Nestle India latest news, Complan misleading claims, Lactogen Pro 1 Powder, Nan Excella Pro Stage 1, Complan 2X Faster Growth, FSSAI misleading advertisements, Zydus Wellness Complan, FSSAI food safety regulations — [Source](https://www.moneycontrol.com/news/business/2x-faster-growth-easy-to-digest-fssai-questions-complan-nestle-claims-seeks-scientific-proof-14056985.html)
- 2026-09-29 — MONEYCONTROL: **Mapro Foods eyeing strategic partner: Zydus Wellness, Blackstone, Apax Partners in fray** — Mapro Foods, Zydus Wellness, Blackstone, Apax Partners — [Source](https://www.moneycontrol.com/news/business/mapro-foods-eyeing-strategic-partner-zydus-wellness-blackstone-apax-partners-in-fray-14040814.html)
- 2026-09-07 — CNBC-TV18: **Zydus Wellness up 8%, PVR Inox down 7%: Check out other Nifty 500 top movers** — Some Nifty 500 stocks rallied at market open, while others slid on an executive exit report and profit booking — here's a look at today's top gainers and losers. — [Source](https://www.cnbctv18.com/market/stocks/zydus-wellness-up-8-pvr-inox-down-7-check-out-other-nifty-500-top-movers-19985230.htm)
- 2026-09-07 — Mint: **Volume shocker stocks today: Why Innovassynth, RIR Power, Pashupati Cotspin, Zydus Wellness are soaring - Data details h** — Volume shocker stocks today: Stocks such as Innovassynth, RIR Power, Pashupati Cotspin, and Zydus Wellness surged in morning deals on Monday, 7 September, amid a spurt in volume. — [Source](https://www.livemint.com/market/stock-market-news/volume-shocker-stocks-today-why-innovassynth-rir-power-pashupati-cotspin-zydus-wellness-are-soaring-data-details-h-11788753849711.html)
- 2026-09-04 — Times of India: **As protein demand rises, brands go for smaller packs** — India Business News: Mumbai: Protein foods are now a common sight across retail shelves, but consumers may increasingly also have the choice to go for smaller-sized portio. — [Source](https://timesofindia.indiatimes.com/business/india-business/as-protein-demand-rises-brands-go-for-smaller-packs/articleshow/133780266.cms)
- 2026-08-26 — Mint: **Raja Venkatraman recommends three stocks for 26 August** — Market expert Raja Venkatraman shares his top stock picks for 26 August. Here’s his technical outlook and trade strategy. — [Source](https://www.livemint.com/market/stock-market-news/raja-venkatraman-recommends-three-stocks-for-26-august-11787669841800.html)
- 2026-08-04 — The Hindu: **Q1 Results Today Live: Wonderla Holidays, Morepen Lab, RITES, Bharat Seats Q1 PAT up y-o-y, Godrej Properties & Zydus Wellness con. PAT decline, Bharti Airtel, ONGC, Pidilite, Marico, Nykaa, Bharti Hexacom, NHPC, MCX, Kalyan Jewellers, Alembic to announce Q1 results** — Q1 Results Today, 4th August 2026 Live Updates: Follow businessline for more — [Source](https://www.thehindubusinessline.com/markets/q1-results-today-live-updates-bharti-airtel-ongc-pidilite-nykaa-marico-nhpc-mcx-godrej-properties-zydus-alembic-rites-kalyan-jewellers-uno-minda-tata-invest-united-breweries-results-04-august-2026/article71300717.ece)
- 2026-08-04 — CNBC-TV18: **Zydus Wellness slips 5% as Q1 profit falls 7%, margin pressure weighs** — Zydus Wellness posted a consolidated net profit of ₹119 crore for the June quarter, compared with ₹128 crore in the corresponding period last year. Revenue from operations surged 67% year-on-year to ₹1,437 crore from ₹860.9 crore. — [Source](https://www.cnbctv18.com/market/zydus-wellness-share-price-slips-q1-results-profit-falls-margin-ebitda-19961305.htm)
- 2026-08-04 — CNBC-TV18: **Sensex Today | Stock Market Live Updates: Nifty at 24,500; Dee Devpt, Godrej Prop shares fall on Q1 results** — Stock Market LIVE Updates: Today's session is not only the weekly options expiry session for the Nifty 50 contracts, but is also set to see supply of paper worth nearly ₹36,000 crore, which includes the mega LIC Offer for Sale (OFS). Earnings season is drawing to a close and therefore, companies are making a beeline to report numbers as well. Adding to that is the confusion surrounding the Closing Auction Session. Watch this space for all the LIVE stock market updates. — [Source](https://www.cnbctv18.com/market/stock-market-live-updates-sensex-nifty-50-today-banks-midcaps-lic-paytm-meesho-kalyan-arvind-bharti-bse-share-price-liveblog-19960944.htm)
- 2026-08-04 — CNBC-TV18: **Q1 Results LIVE Updates: Symphony shares gain post earnings; Godrej Properties management commentary strong** — Q1 Results LIVE Updates: Two Nifty 50 companies Bharti Airtel, ONGC and Ajmera Realty, Alembic Pharma, BSE, Bharti Hexacom, Castrol, Godrej Properties, Greaves Cotton, Kalyan Jewellers, Marico, MCX, Nykaa, Metro Brands, NHPC, Motherson Sumi Wiring, Pidilite, Protean e-GOV, Keystone Realtors, RITES, Saregama, Safari Industries, Sanofi India, Tata Investment, Symphony, United Breweries, Uno Minda, VRL Logistics, Zydus Wellness, Welspun Enterprises, Wonderla Holidays, Prince Pipes, Metropolis Healthcare, CE InfoSystems, are among the other companies reporting their numbers today. Earnings reactions also come from stocks like DLF, IREDA, Torrent Power, and other such names. — [Source](https://www.cnbctv18.com/market/q1-results-live-updates-bharti-airtel-hexacom-ongc-dlf-sbi-funds-ireda-bse-mcx-kalyan-gcpl-marico-nykaa-pidilite-share-price-liveblog-19960965.htm)
- 2026-07-21 — Economic Times: **Qcomm leverages cart clout to draw higher margins from cos** — Quick commerce platforms are increasing demands for higher margins and marketing funds. Consumer goods companies face rising costs for better product visibility and keyword searches. These platforms are now adopting auction-style bidding for marketing activities. This shift pressures companies to invest more for prominent placement and sales. Reliance Retail is renegotiating terms by combining grocery stores and its quick commerce platform. — [Source](https://economictimes.indiatimes.com/industry/services/retail/qcomm-leverages-cart-clout-to-draw-higher-margins-from-cos/articleshow/132523471.cms)
- 2026-07-17 — Mint: **Raja Venkatraman recommends three stocks for 17 July | Stock Market News** — Market expert Raja Venkatraman shares his top stock picks for 17 July. Here’s his technical outlook and trade strategy. — [Source](https://www.livemint.com/market/stock-market-news/raja-venkatraman-recommends-three-stocks-for-17-july-11784248851294.html)

## Business profile

**Strategic vision:** Consumer wellness company with Indian heritage and global presence.

### Business segments
- **Food and Nutrition:** This segment includes a range of food and nutrition products designed to meet consumer health and dietary needs.
- **Dietary Supplements:** The company offers dietary supplements aimed at supporting health and wellness.
- **Pet Care:** This segment focuses on natural and safe food supplements for dogs and cats, primarily for European and US markets.
- **Skincare:** The company provides skincare products to address personal care needs.

### Competitive strengths
- Diverse portfolio of brands across multiple wellness segments.
- Extensive distribution channels including ground sales, business partners, and direct market access.
- Global operational footprint with manufacturing and co-manufacturing facilities.

## Related stocks

- [Allied Blenders and Distillers Limited (FMCG)](https://faxioms.com/stocks/abdl) — +1.42%
- [AWL Agri Business Limited (FMCG)](https://faxioms.com/stocks/awl) — -0.24%
- [Balrampur Chini Mills Limited (FMCG)](https://faxioms.com/stocks/balramchin) — -1.53%
- [Bikaji Foods International Limited (FMCG)](https://faxioms.com/stocks/bikaji) — -3.13%
- [CCL Products (India) Limited (FMCG)](https://faxioms.com/stocks/ccl) — +0.50%

## Freshness and sources

- Data as of: 2026-11-06
- Source: Faxioms public stock analysis API

Canonical: https://faxioms.com/stocks/zyduswell
Markdown representation: https://faxioms.com/stocks/zyduswell?render=md